NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NEPHROS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$3.68+0.03 (+0.82%)
Close on Oct 19, 2026
- Market cap
- $40.89M
- P/E (TTM)
- 23.0
- Dividend yield
- –
Community
Notes and questions about Nephros from other investors
No posts about NEPH yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.